Meng Ling Moi (Sherry)




Affiliations

  • Associate Professor, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan (2015-present)
  • Deputy-Director, WHO Collaboration Centre for Reference and Research on Tropical and Emerging Virus Diseases (2015-present)
  • Collaborative Researcher, National Institute of Infectious Diseases, Tokyo, Japan (2015-present)
  • Researcher, Department of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan (2010-2014)


Qualifications

  • Ph.D. in Medicine, Tsukuba University, Graduate School of Comprehensive Human Sciences (2006-2010)
  • M.Sc. in Medical Sciences, Tsukuba University, Graduate School of Comprehensive Human Sciences (2004-2006)
  • B.Sc. (Hons) Microbiology, Universiti Putra Malaysia, Faculty of Science and Environmental Science, First Class Honours  (1999-2002)


Awards

  • December 2016:Incentive Prize, MSD Life Science Foundation (Press release)
  • April 2016:Young Scientist Prize, Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology (Press release)
  • January 2015:Female Researcher Grant, MSD Life Science Foundation 
  • November 2014:26th International Meeting Award, Kato Memorial Bioscience Foundation, 
  • November 2014:Ishibashi Memorial Lecture, International Medical Society of Japan
  • October 2014:Special Prize, Science Cafe, National Institute of Infectious Disease
  • November 2013:Malaysia Japan Academic Conference, Best Poster Award
  • March 2010:Tsukuba University, Graduate School of Human Sciences, Dean’s Award for Research Excellence
  • April 2003 –March 2010: Monbukagakusho Scholarship Award, Japan (Ph.D., M.Sc. studies)
  • 1999-2002: Dean's List, for all academic semesters
  • 1999: Best Student of the Year, BSc Microbiology                      


Research Themes

  • Role of protective and infection-enhancing antibodies in the pathogenesis of mosquito-borne virus infection.
  • Development and evaluation of new tools for dengue vaccine efficacy evaluation: in vitro and in vivo models
  • Development and evaluation of diagnostic tools for mosquito-borne diseases
  • Epidemiological studies on dengue & other tropical diseases
  • Travel-related tropical diseases: impacts on endemic and non-endemic regions

 

Research Publications

(1) Publications in Journals & Sites

  1. Moi ML, Nguyen TTT, Nguyen CT, Vu TBH, Tun Ngwe MM, Pham TD, Pham NT, Tran T, Morita K, Le TQM, Dang DA, Hasebe F. Zika virus infection and microcephaly in Vietnam. Lancet Infect Dis, in press.  
  2. Kyaw AK, Ngwe Tun MM, Moi ML, Nabeshima T, Soe KT, Thwe SM, Myint AA, Maung KTT, Aung W, Hayasaka D, Buerano CC, Thant KZ, Morita K. Clinical, virological and epidemiological characterization of dengue outbreak in Myanmar, 2015.Epidemiol Infect. 2017;145(9):1886-1897. 
  3. Yamanaka A, Moi ML, Takasaki T, Kurane I, Matsuda M, Suzuki R, Konishi E.Utility of Japanese encephalitis virus subgenomic replicon-based single-roundinfectious particles as antigens in neutralization tests for Zika virus and threeother flaviviruses. J Virol Methods. 2017;243:164-171. 
  4. Yamanaka A, Moi ML, Takasaki T, Kurane I, Konishi E. Neutralizing and enhancing antibody responses to five genotypes of dengue virus type 1 (DENV-1) in DENV-1 patients. J Gen Virol. 2017 Feb;98(2):166-172. 
  5. Moi ML, Kobayashi D, Isawa H, Sasaki T, Saijo M, Kurane I, Sawabe K, Takasaki T. Dengue virus isolation in mosquito Aedes albopictus captured during an outbreak in Tokyo, 2014, by a method relying on antibody-dependent enhancement mechanism using FcgR-expressing BHK cells. Vector Borne Dis, 16(12):810-812, 2016.
  6. Ngwe Tun MM, Muthugala RV, Thuy NT, Ly PH, Thu LT, Dinh DT, Hoang NV, Mai LT, Moi ML, Buerano CC, Morita K, Hasebe F. Dengue-associated acute encephalitis syndrome cases in Son La Province, Vietnam in 2014. Jpn J Infect Dis., in press.
  7. Saito Y, Moi ML, Takeshita N, Lim CK, Shiba H, Hosono K, Saijo M, Kurane I, Takasaki T. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults. BMC Infect Dis.;16(1):578, 2016.
  8. Nakajima S, Watashi K, Ohashi H, Kamisuki S, Izaguirre-Carbonell J, Kwon AT, Suzuki H, Kataoka M, Tsukuda S, Okada M, Moi ML, Takeuchi T, Arita M, Suzuki R, Aizaki H, Kato T, Suzuki T, Hasegawa H, Takasaki T, Sugawara F, Wakita T. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System. J Virol.90(20):9058-74, 2016.
  9. Nakayama E, Kotaki A, Tajima S, Kawada M, Miura K, Gemma A, Adachi T, Sekizuka T, Kato K, Yamashita A, Moi ML, Ikeda M, Yagasaki K, Shibasaki K, Saijo M, Kuroda M, Takasaki T. Two different dengue virus strains in the Japanese epidemics of 2014. Virus Genes;52(5):722-6, 2016.
  10. Ngwe Tun MM, Kyaw AK, Makki N, Muthugala R, Nabeshima T, Inoue S, Hayasaka D, Moi ML, Buerano CC, Thwe SM, Thant KZ, Morita K. Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype. Infect Genet Evol. 2016;43:31-7, 2016.
  11. Tajima S, Nakayama E, Kotaki A, Moi ML, Ikeda M, Yagasaki K, Saito Y, Shibasaki KI, Saijo M, Takasaki T. Whole genome sequencing-based molecular epidemiologic analysis of autochthonous dengue virus type 1 strains circulating in Japan in 2014. Jpn J Infect Dis. 2016, in press.
  12. Shinohara K, Kutsuna S, Takasaki T, Moi ML, Ikeda M, Kotaki A, Yamamoto K, Fujiya Y, Mawatari M, Takeshita N, Hayakawa K, Kanagawa S, Kato Y, Ohmagari N. Zika fever imported from Thailand to Japan, and diagnosed by PCR in the urines. J Travel Med. 23(1), 2016.
  13. Tajima S, Yagasaki K, Kotaki A, Tomikawa T, Nakayama E, Moi ML, Lim CK, Saijo M, Kurane I, Takasaki T. In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain. J Gen Virol. 96(9):2661-9, 2015.
  14. Moi ML, Honma Y, Mori S, Kuze T, Kanekawa M, Isoda T, Moriwaki N, Hosogai T, Kotaki A, Kurane I, Saijo M, Miyake S, Takasaki T. Virological confirmation of concurrent dengue virus serotypes-1 and serotype-4 by virus isolation using Fcgamma receptor expressing BHK cells. International Journal of Infectious Diseases, 33:177-8, 2015.
  15. Saito Y, Moi ML, Kotaki A, Ikeda M, Tajima S, Shiba H, Hosono K, Saijo M, Kurane I, Takasaki T. Detection of dengue virus nonstructural protein 1 (NS1) in urine samples using ELISA as a laboratory diagnostic method for dengue virus infection. Japanese Journal of Infectious Diseases, 68(6):455-60, 2015. 
  16. Moi ML, Ami Y, Shirai K, Lim CK, Suzaki Y, Saito Y, Kitaura K, Saijo M, Suzuki R, Kurane I, Takasaki T. Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus. American Journal of Tropical Medicine and Hygiene,92(2):92(2):370-6, 2015.
  17. Kutsuna S, Kato Y, Moi ML, Kotaki A,  Ota M, Shinohara K, Kobayashi T, Yamamoto K, Fujiya Y, Mawatari M, Takeshita N, Hayakawa K, Kanagawa S, Takasaki T, Ohmagari N. Autochthonous Dengue Fever, Tokyo, Japan, 2014. Emerging Infectious Diseases, 21(3):517-20, 2015. 
  18. Moi MLKotaki A, Tajima S, Ikeda M, Yagasaki K, Lim CK, Kinoshita H, Nakayama E, Saito Y, Kurane I, Oishi K, Saijo M, Takasaki T.Trends of imported dengue fever cases in Japan, 2010 to 2013. Dengue Bulletin, in press.
  19. Tajima S, Kotaki A, Yagasaki K, Taniwaki T, Moi ML, Nakayama E, Saijo M, Kurane I, Takasaki T. Identification and amplification of Japanese encephalitis virus and Getah virus propagated from a single porcine serum sample: A case of coinfection. Archives of Virology. 159(11):2969-75, 2014.
  20. Moi ML, Takasaki T, Omatsu T, Nakamura S, Katakai Y, Ami Y, Suzaki Y, Saijo M, Akari H, Kurane I. Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans. Journal of General Virology, 95(Pt 3):591-600, 2014.
  21. Moi ML, Takasaki T, Saijo M, Kurane I. Determination of antibody concentration as main parameter in a dengue virus antibody-dependent enhancement assay using FcγR-expressing BHK cells. Archives of Virology, 159(1):103-16, 2014.
  22. Kutsuna S, Kato Y, Takasaki T, Moi ML, Kotaki A, Uemura H, Matono T, Fujiya Y, Mawatari M, Takeshita N, Hayakawa K, Kanagawa S, Ohmagari N. Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014. Euro Surveillence,19(4). pii: 20683, 2014
  23. Tochitani K, Shimizu T, Shinohara K, Tsuchido Y, Moi ML, Takasaki T. A first case report of Ross River virus disease patient in Japan who came back from Australia. The  Journal of the Japanese Association of Infectious Diseases88:155-159, 2014.
  24. Moi ML, Omatsu T, Hirayama T, Takasaki T, Nakamura S, Tajima S, Ito M, Yoshida T, Saito A, Katakai Y, Akari H, Kurane I. Presence of viral genome in urine and development of hematuria in common marmosets (Callithrix jacchus) after inoculation with dengue virus. Pathogens, 2,357-363,2013       
  25. Moi ML, Takasaki T, Kurane I. Efficacy of tetravalent dengue vaccine in Thai schoolchildren. Lancet, 381,9872,1094, 2013. <Letter to Editor>
  26. Moi ML, Omatsu T, Tajima S, Lim CK, Kotaki A, Ikeda M, Harada F, Ito M, Saijo M, Kurane I, Takasaki T. Detection of dengue virus non-structural protein 1 (NS1) by using ELISA as a useful laboratory diagnostic method for dengue virus infection of international travellers. Journal of Travel Medicine, 20,3,185-193,2013 
  27. Moi ML, Lim CK, Takasaki T, Kurane I. Infection-enhancement activity in dengue patients using undiluted serum samples. Transactions of the Royal Society of Tropical Medicine and Hygiene, 107,51-58,2013
  28. Ujiie M, Moi ML, Kato Y, Takasaki T. Diagnosis of viral haemorrhagic fevers in travelers returning from West Africa. Journal of Travel Medicine, 20(1), 63-64, 2013. <Letter to Editor>
  29. Ujiie M, Moi ML, Kobayashi T, Takeshita N, Kato Y, Takasaki T, Kanagawa S. Dengue virus type-3 infection in a traveler returning from Benin to Japan. Journal of Travel Medicine, 19,4,255-257, 2012
  30. Omatsu T, Moi ML, Takasaki T, Nakamura S, Katakai Y, Tajima S, Ito M, Yoshida T, Saito A, Akari H, Kurane I. Changes in hematological and serum biochemical parameters in common marmosets (Callithrix jacchus) after inoculation with dengue virus. Journal of Medical Primatology, 41,5,289-296,2012 
  31. Moi ML, Lim CK, Chua KB, Takasaki T, Kurane I. Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells. PLoS Neglected Tropical Diseases, 6(2),e1536, 201 [PAPER OF THE MONTH, International Society of Vaccines, March 2012]
  32. Takasaki T, Kotaki A, Tajima S, Omatsu T, Harada F, Lim CK, Moi ML, Ito M, Ikeda M, Kurane I. Demographic features of imported dengue fever and dengue haemorrhagic fever in Japan from 2006 to 2009. Dengue Bulletin, 35,217-222, 2012
  33. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR negative cells in secondary infection but not in primary infection. Journal of Infectious Diseases, 203(10),1405-1414, 2011
  34. Moi ML, Lim CK, Tajima S, Kotaki A, Saijo M, Takasaki T, Kurane I. Dengue virus isolation relying on antibody-dependent enhancement mechanism using FcγR-expressing BHK cells and a monoclonal antibody with infection-enhancing capacity. Journal of Clinical Virology. 52(3),225-230, 2011
  35. Ujiie M, Moi ML, Takeda N. Dengue maculopathy in a traveler. American Journal of Tropical Medicine and Hygiene. 85(6),965-966, 2011
  36. Omatsu T, Moi ML, Hirayama T, Takasaki T, Nakamura S, Tajima S, Ito M, Yoshida T, Saito A, Katakai Y, Akari H, Kurane I. Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viremia and demonstration of protective immunity. Journal of General Virology. 92,2272-2280,2011
  37. Moi ML, Takasaki T, Kotaki A, Tajima S, Lim CK, Sakamoto M, Iwagoe H, Kobayashi K, Kurane I. Importation of dengue virus type 3 to Japan from Tanzania and Cote d'Ivoire. Emerging Infectious Diseases. 16(11),1770-1772,2010
  38. Yamamoto K, Matumoto K, Lim CK, Moi ML, Kotaki A, Takasaki T. Chikungunya fever from Malaysia. Internal Medicine. 49(5),501-505, 2010
  39. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Discrepancy in dengue virus neutralizing antibody titers between plaque reduction neutralizing tests with Fcgamma receptor (FcgammaR)-negative and FcgammaR-expressing BHK-21 cells. Clinical Vaccine and Immunology. 17(3), 402-407, 2010
  40. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA. Journal of Virological Methods. 163(2),205-209,2010
  41. Moi ML, Lim CK, Takasaki T, Kurane I. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. Journal of General Virology. 91(Pt 1),103-111,2010.
  42.  Moi ML, Ujiie M, Takasaki T, Kurane I. Dengue virus infection in travellers returning from Benin to France, July – August, 2010. Eurosurveillance, 15(39):pii=19674, 2010. <Letter to Editor>
  43. Takasaki T, Kotaki A, Lim CK, Tajima S, Omatsu T, Moi ML, Kurane I. Arbovirus Infections: the challenges of controlling an ever-present enemy. Journal of Disaster Research, (5),322-327,2009.

 

(2) Publications in Japanese

  1. Moi ML, Takasaki T.微生物ABC: デングウイルスのウイルス学的特徴. up-to-date子供の感染症.3:1, pp18-23, 2015.
  2. Moi ML, Takasaki T.デング熱・出血熱と免疫機構臨床免疫・アレルギー科 63:3, pp293-298, 2015.
  3. Moi ML, Takasaki T.帰国後診療:デング熱.実地医家のための渡航医療. 診断と治療.102:4, pp560-566, 2014.
  4. Moi ML, Takasaki T.マレー渓谷脳炎ウイルス.神経症候群I. 26: pp607-612, 2014
  5. Moi ML, Saijo M. 抗アルボウイルス薬. 臨床と微生物.40(1), 69-73, 2013
  6. Moi ML, Takasaki T. 感染症迅速診断キットの有用性と限界:デング熱. 小児科,53(4), 457-465, 2012.
  7. Moi MLTakasaki T. デング熱. デング出血熱. 小児感染症学(編集岡部信彦), 508-511, 2011.
  8. Moi MLクロアチアにおけるデング熱の流行. Infectious Agents Surveillance Report, 32 (6), 165 – 167. 2011.
  9. Moi ML, Takasaki T, Iwagoe H, Sakamoto M, Kobayashi K, Ujiie M. アフリカからのデング熱輸入例. Infectious Agents Surveillance Report, 32 (6), 164 – 165. 2011. 
  10. Moi MLTakasaki T. アジア渡航米国人における日本脳炎の3症例.2003~2007年-米国. Infectious Agents Surveillance Report 30:244-245,2009
  11. Moi ML, Kurane I. 輸入感染症の可能性がある希少感染症-デング熱・デング出血熱. 科学療法の領域, 24(11) 1592-1598. 2008. 
  12. Takasaki T, Moi ML. 地球温暖化に伴う新規感染症. Clinician, 55 (570), 732-734. 2008.

 (3) Publications in sites

  1. Tochitani K, Shimizu T, Shinohara K, Tsuchido Y, Moi ML, Takasaki T. Ross River virus - Japan ex Australia: (VI). ProMed, promed archive no. 20130616.1776324, 2013. 
  2. Kikuchi T, Shimizu S, Okame M, Koibuchi T, Moi ML, Kotaki A, Takasaki T. Dengue-importations into Japan from East Timor-3 cases-DENV-3. ProMed, promed archive no. 20120319.1074013, 2012
  3. Moi ML, Takasaki T, Kotaki A, Tajima S, Lim CK, Omatsu T, Kurane I. Dengue importations into Japan from Bali. ProMed, promed archive no. 20100329.09. 2010. 
  4. Takasaki T, Moi ML, Kotaki A, Sakamoto M, Kobayashi K, Kurane I. Dengue importations into Japan from Tanzania. ProMed, promed archive no. 20100323.0922. 2010.

Conference & Meetings

  1. Moi ML, Takasaki T. Differential Diagnosis with other Flavivirus: New developments and challenges in differential diagnosis. Bi-Regional Workshop on Strengthening the Capacity of Japanese Encephalitis (JE) Laboratory Network in the WHO South-East Asia and Western Pacific Region (Bangkok), Aug 2015.
  2. Moi ML. デングウイルスのADEと重症化機構、ワクチン開発.感染研シンポジウム(東京)2015年6月.
  3. Moi ML, Rattanamahaphoom J, Lim CK, Sirivichayakul C, Saijo M, Sabchareon A, Takasaki T, Kurane I. Neutralizing antibody titers as a surrogate for protection against dengue: a revisit of neutralizing antibody titers of dengue virus using FcγR-expressing cells. Joint International Tropical Meeting (JITMM) (Bangkok), December, 2014.
  4. モイメンリン. デングワクチンの実用化への展望.石橋記念講演 (東京) 2014年11月招待講演>
  5. Moi ML, Shirai K, Ami Y, Lim CK, Suzaki Y, Kitaura K, Saijo M, Suzuki R, Takasaki T, Kurane I. Development of a non-human primate model for primary and secondary dengue virus infection using marmosets (Callithrix jacchus). The 63rd Annual Meeting of the American Society of Tropical Medicine and Hygiene (New Orleans, Lousiana, USA) November, 2014
  6. Moi ML, Shirai K, Ami Y, Miyata Y, Lim CK, Suzaki Y, Kitaura K, Saijo M, Suzuki R, Kurane I, Takasaki T. Demonstration of common marmosets (Callithrix jacchus) as a non-human primate model for dengue vaccine development.  62 日本ウイルス学会学術集会. (東京) 2014  11   
  7. 齋藤悠香、モイメンリン、小滝徹、池田真紀子、田島茂、司馬肇、細野邦昭、西條政幸、倉根一郎、高崎智彦. 尿中デングウイルス非構造タンパク(NS1)抗原のELISA法による検出.  55回日本熱帯医学会大会. (東京) 2014  11 
  8. 齋藤悠香、モイメンリン、竹下望、林昌宏、司馬肇、細野邦昭、西條政幸、倉根一郎、高崎智彦. FcγR発現細胞を用いた新規中和アッセイにて日本脳炎ワクチン接種者におけるデングウイルスに対する中和・感染増強の検討.  62 日本ウイルス学会学術集会. (東京) 2014  11  
  9. 山中敦史、モイメンリン、高崎智彦、倉根一郎、小西英二.デング1型ウイルスの遺伝子型がヒトにおける中和・感染増強応用に及ぼす影響.  62 日本ウイルス学会学術集会. (東京) 2014  11   
  10. 高崎智彦、モイメンリン、網康至、須崎百合子、大松勉、平山隆則、田島茂、林昌宏、中村紳一郎、片貝裕子、吉田友 教、明宏文、白井顕治、北浦一孝、藤井克樹、鈴木隆二、西條政幸、倉根一郎.第3回日本マーモセット研究会、マーモセットを用いたデングウイルス感染病態解析(九州)201312
  11. Moi ML, Omatsu T, Tajima S, Lim CK, Saijo M, Kurane I, Takasaki T. Application of the dengue non-structural protein 1 (NS1) ELISA for the detection of dengue virus infection in travelers. Fifth Informal Japanese Encephalitis Laboratory Meeting. (Tokyo) November, 2013
  12. Moi ML, Omatsu T, Nakamura S, Ami Y, Katakai Y, Suzaki Y, Saijo M, Akari H, Kurane I, Takasaki T. Development of a novel non-human primate model for secondary dengue virus infection using marmosets (Callithrix jacchus). 61回日本ウイルス学会学術集会 (神戸) 201311
  13. 齋藤悠香、モイメンリン、林昌宏、司馬肇、細野邦昭、西條政幸、倉根一郎、高崎智彦.日本脳炎ワクチン接種により誘 導された抗体のデングウイルスに対する免疫反応の検討. 61回日本ウイルス学会学術集会 (神戸) 201311
  14. 齋藤悠香、モイメンリン、林昌宏、司馬肇、細野邦昭、西條政幸、倉根一郎、高崎智彦.日本脳炎ワクチン接種により誘 導された抗体のデングウイルスに対する中和活性および感染増強活性の検討. 20回トガ・ペスチ・フラビウイルス研究会 (神戸) 201311 <<斉藤悠香、奨励賞>>
  15. Moi ML, Kurane I, Takasaki T. Development of tools for advancing dengue pathogenesis and vaccine research. Malaysia-Japan Academic Scholar Conference. (Tokyo) November, 2013, <<BEST POSTER AWARD>>
  16. Moi ML, Lim CK, Nakayama E, Tajima S, Kotaki A, Ikeda M, Saijo M, Kurane I, Takasaki T. Imported cases of chikungunya and Ross River fever in Japan. Chikungunya, 2013. (Langkawi, Malaysia) October, 2013
  17. Lim CK, Takasaki T, Moi ML, Nakayama E, Kotaki A, Chua KB, Saijo M, Kurane I. Molecular analysis of Chikungunya virus in Malaysia. Chikungunya, 2013. (Langkawi, Malaysia) October, 2013.
  18. 栃谷健太郎、清水恒広、篠原浩、土戸康弘、高崎智彦、モイメンリンオーストラリア渡航中に発症した本邦初のロスリバーウイルス感染症1. 56回日本感染症学会西日本地方学会学術集会 (大阪) 201311月 
  19.  Moi ML, Lim CK, Kurane I, Saijo M, Takasaki T. Towards a safe and effective dengue vaccine: assessment of dengue neutralizing antibody and viremia titers using a novel assay by FcgammaR-expressing cells. 54th Annual Meeting for the Japanese Society of Tropical Medicine. (Nagasaki) October, 2013. 
  20. Takasaki T, Ikeda M, Yagasaki K, Moi ML, Nakayama E, Kotaki A, Saito Y, Tajima S, Kurane I, Jee Y. JE as a vaccine preventable disease: laboratory network organized by WHO. 第48回日本脳炎ウイルス生態学研究会 (Atami, Shizuoka) May, 2013.
  21. Moi ML, Lim CK, Saijo M, Takasaki T, Kurane I. Re-assessment of dengue neutralizing antibody and viremia titers in dengue patients using FcγR-expressing cells. The 61st Annual Meeting of the American Society of Tropical Medicine and Hygiene (Atlanta, USA) November, 2012  
  22. Ujiie M, Moi ML, Kato Y, Kotaki A, Takeshita N, Kanagawa S, Takasaki T, Ohmagari N. Dengue fever outbreak among Japanese construction workers returning from India. The 61st Annual Meeting of the American Society of Tropical Medicine and Hygiene (Atlanta, USA) November, 2012  
  23. Moi ML, Omatsu T, Nakamura S, Takasaki T, Ami Y, Katakai Y, Suzaki Y, Akari H, Kurane I. Role of antibodies in dengue infection and protective immunity during secondary infection of marmosets. 60回日本ウイルス学会学術集会 (大阪) 201211
  24. 小滝徹、モイメンリン、田島茂、高崎智彦. ウイルスRNA安定保存キットの評価, 60回日本ウイルス学会学術集会 (大阪) 201211
  25. 林昌宏、網康至、藤井克樹、北浦一孝、モイメンリン、白井顕治、小滝徹、須崎百合子、森川茂、西條政幸、鈴木隆二、倉根一郎、高崎智彦. マーモセットを用いたチクングンニヤウイルスの霊長類モデルの検討, 60回日本ウイルス学会学術集会 (大阪) 201211
  26. Moi ML, Lim CK, Saijo M, Takasaki T, Kurane I. Dengue vaccine development: re-assessment fo dengue neutralizing antibody and viremia titers using FcγR-expressing cells. The 34th Naito Conference: Infection, immunity and their control for health (Hokkaido) October, 2012  
  27. Azami NAM, Moi ML, Takasaki T, Salleh SA, Neoh HM, Othman Z, Shah SA, Kurane I, Jamal R. Serological evidence of the co-circulation of multiple dengue virus serotypes in Kuala Lumpur, Malaysia. 13th Asia-Pacific Congress on Clinical Microbiology and Infection. (Beijing, China) October, 2012.
  28. Ujiie M, Moi ML, Kato Y, Kanagawa S, Ohmagari N, Takeshita N, Takasaki T. Ocular complications associated with imported dengue fever. 9 th Asia Pacific Travel Health Conference in conjunction with the 5th Regional Meeting of the International Society of Travel Medicine. (Singapore) May 2012.
  29. Moi ML, Omatsu T, Tajima S, Lim CK, Saijo M, Kurane I, Takasaki T. Application of the dengue non-structural protein 1 (NS1) ELISA for the detection of dengue virus infection in travelers. 9 th Asia Pacific Travel Health Conference in conjunction with the 5th Regional Meeting of the International Society of Travel Medicine. (Singapore) May 2012.
  30. Moi ML, Lim CK, Saijo M, Kurane I, Takasaki T. デング熱診断サーベイランスのためのNS1抗原検出診断キット.   86th Annual Meeting of the Japanese Association for Infectious Diseases (Nagasaki, Japan) April 2012.
  31. Lim CK, Takasaki T, Moi ML, Kotaki A, Kurane I, Saijo M. Molecular diagnosis and analysis of imported Chikungunya virus strains, Japan, 2006-2010. The 60th Annual Meeting of the American Society for Tropical Medicine and Hygiene, (Philadelphia, PA) December 2011
  32. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection. International Congress of Virology. (北海道) 2011 9.
  33. Lim CK, Ami Y, Fujii Y, Moi ML, Kitaura K, Kotaki A, Morikawa S, Saijo M, Suzuki R, Kurane I, Takasaki T. Pathogenesis of epidemic chikungunya virus in nonhuman primates. International Congress of Virology. (北海道) 2011 9.
  34. Moi ML, Lim CK, Ito M, Takasaki T, Kurane I. Antibody-dependent enhancement of dengue virus infection: revisit of antibody response and viremia in dengue patients using FcγR-expressing cells. 45th Joint Working Conference on Immunology and Viral Diseases, US-Japan Cooperative Medical Science Program. (Stanford University, カリフォルニア, 米国) 20116.
  35. モイメンリン, 大松勉, 高崎智彦, 中村紳一朗, 片貝祐子, 文宏明里, 倉根一郎. Marmoset as a tool for vaccine efficacy evaluation. 17 回トガ・フラビ・ペスチウイルス研究会 (東京) 201012
  36. 昌宏、藤本嗣人、小長谷昌未、モイ メンリン、小滝徹、倉根一郎、高崎 智彦.   近年のチクングニヤ熱の流行と迅速診断法の検討, 58回日本ウイルス学会学術集会 (徳島) 201011
  37. モイメンリン, 林昌宏, 小滝徹, 高崎智彦, 倉根一郎. デングウイルス再感染患者血清中ウイルス力価の検討:感染性抗体デングウイルス複合体はFcγR発現細胞においてのみ検出された. 58 日本ウイルス学会学術集会. (徳島) 2010 11  
  38. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Titration of neutralizing antibody and viremia in dengue patients using FcγR-expressing cells. 14th International Conference on Emerging Infectious Diseases (EID) in the Pacific Rim. Malaysia (Pulau Pinang, Malaysia) 201010.
  39. 水野康孝、加藤康幸、竹下望、氏家無限、金川修造、工藤宏一郎、モイメンリン、高崎智彦. 輸入デング熱40例の臨床的検討. 59回日本感染症学会東日本地方会.(東京) 201010
  40. Takasaki T, Moi ML, Lim CK, Kurane I. Imported Chikungunya fever and dengue fever in JAPAN. The 7th Japan-Taiwan Symposium on Immunization and Travel Medicine. (Taipei, Taiwan) September 2010
  41. Lim CK, Takasaki T, Moi ML, Omatsu T, Kotaki A, Chua KB, Kurane I. Molecular diagnosis and analysis of Chikungunya virus in Malaysia. The 8th Japan-China International Conference of Virology. (Harbin, China) July 2010
  42. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Dengue virus enhancing activity in serum samples from dengue patients determined using FcγR-expressing BHK cells. 44th Joint Working Conference on Viral Diseases, US-Japan Cooperative Medical Science Program. (Sapporo) June 2010
  43. Lim CK, Takasaki T, Moi ML, Omatsu T, Kotaki A, Chua KB, Kurane I. Molecular diagnosis and analysis of Chikungunya virus in Malaysia. The ninth International Symposium on Positive-Strand RNA viruses. (Atlanta, USA) May 2010
  44. 林昌宏、高崎智彦、モイメンリン、大松勉、倉根一郎. 近年のチクングニヤ熱流行におけるチクングニヤ熱疑い患者血清の病原および血清学的解析.84回感染症学会そうか学術集会 (京都) 20104
  45. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Development of antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing FcγRIIA. 58th Annual Meeting. American Society of Tropical and Medicine and Hygiene. (ワシントン、米国) 200911.
  46. モイメンリン,林昌宏,小滝徹,高崎智彦,倉根一郎. FcγRIIA発現BHK-21細胞を用いた抗デングウイルス抗体依存性感染増強(ADE)アッセイの開発.第57回日本ウイルス学会 (東京) 200910
  47. 林昌宏,高崎智彦,モイメンリン,大松勉,小滝徹,倉根一郎.東南アジアにおけるチクングニヤ熱疑い患者血清の病原体および血清学的解析.第57回日本ウイルス学会 (東京) 200910
  48. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I. Discrepancy in viremic titers in dengue serum samples between BHK cells and FcγR-expressing BHK cells. 16 トガ・フラビ・ペスチウイルス研究会 (東京) 200910
  49. Moi ML, Lim CK, Takasaki T, Kurane I. Role of FcγIIA in ADE of DENV  infection. 56回日本ウイルス学術集会.(岡山). 200810
  50. Moi ML, Lim CK, Takasaki T, Kurane I. Role of FcγIIA in ADE of DENV  infection. 15回トガ・フラビ・ペスチウイルス研究会. (岡山)200810
  51. Moi ML, Lim CK, Takasaki T, Kurane I. Role of FcγIIA in ADE of DENV infection. The 2nd International Conference on Dengue and Dengue Hemorrhagic Fever: Global Invention to Fight Dengue. (Phuket, Thailand). 200810
  52. Moi ML, Lim CK, Takasaki T, Kurane I. Determination of the regions in human FcγIIA responsible for antibody dependent enhancement of dengue virus infection. 7th Japan-China International Conference of Virology. (東京) 20086
  53. 林昌宏,根路銘令子,小山田敏文,清水良太,田島茂,貫井陽子,水野俊秀,大松勉,小滝徹,モイメンリン,池田真紀子,倉根一郎,高崎智彦.三重県の同一農場から分離された日本脳炎1型ウイルスのマウスにおける病原性解析.第43回日本脳炎ウイルス生態学研究会 (観音寺市) 20085

 



Inquiries on dengue research:
sherrymoi@yahoo.com




Showing 0 items
StatusOwnerFeatureDesign (URL)
Sort 
 
Sort 
 
Sort 
 
Sort 
 
StatusOwnerFeatureDesign (URL)
Showing 0 items
Comments